Oscar Health, Inc. (OSCR)
Automate Your Wheel Strategy on OSCR
With Tiblio's Option Bot, you can configure your own wheel strategy including OSCR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OSCR
- Rev/Share 44.198
- Book/Share 4.0208
- PB 4.5069
- Debt/Equity 0.6702
- CurrentRatio 0.9461
- ROIC -0.132
- MktCap 4615421330.0
- FreeCF/Share 2.8801
- PFCF 6.274
- PE -18.9089
- Debt/Assets 0.1194
- DivYield 0
- ROE -0.2156
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | OSCR | Piper Sandler | Neutral | Overweight | -- | $25 | Nov. 26, 2025 |
| Initiation | OSCR | Goldman | -- | Neutral | -- | $17 | Oct. 14, 2025 |
| Downgrade | OSCR | Robert W. Baird | Outperform | Neutral | -- | $14 | July 25, 2025 |
| Downgrade | OSCR | UBS | Neutral | Sell | -- | $11 | July 15, 2025 |
| Downgrade | OSCR | Piper Sandler | Overweight | Neutral | -- | $14 | July 14, 2025 |
| Downgrade | OSCR | Wells Fargo | Equal Weight | Underweight | -- | $10 | July 11, 2025 |
| Initiation | OSCR | Barclays | -- | Underweight | -- | $17 | July 2, 2025 |
| Downgrade | OSCR | Raymond James | Outperform | Market Perform | -- | -- | June 24, 2025 |
| Downgrade | OSCR | Wells Fargo | Overweight | Equal Weight | $20 | $16 | March 13, 2025 |
| Initiation | OSCR | Jefferies | -- | Underperform | -- | $12 | Dec. 10, 2024 |
News
Why This Health Care Stock Has Gained 35% This Week
Published: November 26, 2025 by: Investopedia
Sentiment: Positive
Shares of Oscar Health (OSCR) jumped Wednesday, the latest big gain for the health insurer after Piper Sandler analysts upgraded their rating of the stock in a recent note to clients.
Read More
OSCR Stock Review: Strong Growth Meets Attractive Valuation
Published: November 25, 2025 by: Forbes
Sentiment: Positive
Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via the Affordable Care Act (ACA) Marketplace. This surge signifies investor confidence regarding imminent policy support, yet the central question persists: Is OSCR stock still an enticing purchase following its recent increase?
Read More
Anticipation of This Trump Proposal Is Sending Health Insurance Stocks Higher Monday
Published: November 24, 2025 by: Investopedia
Sentiment: Positive
Shares of several major health insurers surged Monday following reports President Donald Trump could be set to unveil a healthcare proposal that would extend Affordable Care Act subsidies.
Read More
Oscar Health Stock Surges 22% and Centene Jumps 10%. Here's Why.
Published: November 24, 2025 by: Barrons
Sentiment: Positive
The White House is planning to propose a two-year extension for Affordable Care Act subsidies, according to a report.
Read More
Obamacare Stock Stung by Potential Healthcare Disruption
Published: November 10, 2025 by: Schaeffers Research
Sentiment: Negative
Oscar Health Inc (NYSE:OSCR) is sitting out today's broad market rally , last seen down 15.9% to trade at $14.98.
Read More
Oscar Health Misses Q3 Revenue, Loss Widens To $129 Million Despite Membership Surge
Published: November 06, 2025 by: Benzinga
Sentiment: Negative
Oscar Health Inc. (NYSE: OSCR) reported third-quarter revenue of approximately $2.99 billion, compared to $2.4 billion a year ago, missing the consensus estimate of $3.08 billion.
Read More
Compared to Estimates, Oscar Health (OSCR) Q3 Earnings: A Look at Key Metrics
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Oscar Health (OSCR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Oscar Launches New Affordable Health Insurance Choices for Orlando Individuals, Families, and Businesses
Published: November 05, 2025 by: Business Wire
Sentiment: Neutral
ORLANDO, Fla.--(BUSINESS WIRE)--Oscar Health introduces new health plans for individuals, families, and businesses in Orlando on the individual marketplace for 2026 Open Enrollment.
Read More
Oscar Launches New Affordable Health Insurance Choices for Tampa Individuals, Families, and Businesses
Published: November 05, 2025 by: Business Wire
Sentiment: Neutral
TAMPA, Fla.--(BUSINESS WIRE)--Oscar Health introduces new health plans for individuals, families, and businesses in Tampa on the individual marketplace for 2026 Open Enrollment.
Read More
Oscar Launches New Affordable Health Insurance Choices for Charlotte Individuals and Families
Published: November 05, 2025 by: Business Wire
Sentiment: Neutral
CHARLOTTE, N.C.--(BUSINESS WIRE)--Oscar Health offers affordable, tech-powered plans for individuals and families in Charlotte on the individual marketplace for 2026 Open Enrollment.
Read More
Oscar Health: What The US Government Shutdown Means To The Company
Published: October 08, 2025 by: Seeking Alpha
Sentiment: Positive
Oscar Health (OSCR) faces uncertainty as the expiration of enhanced ACA premium tax credits could impact membership and margins. Oscar's growth is supported by rising Individual Coverage Health Reimbursement Arrangements (ICHRA), expanding its addressable market and revenue potential. If subsidies are extended, Oscar will able to continue to grow their member base and eventually reach profitability.
Read More
Bear of the Day: Oscar Health (OSCR)
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
Oscar Health ( OSCR ) is a $5 billion digital health-insurance company that was expected to see a strong rise to profitability this year into 2026. But even after raising top line guidance this year to $12-12.2 billion from $11.2-11.3 billion, analysts reversed course on their EPS forecast by moving the consensus from $0.61 to a loss of $1.42 in the past few months.
Read More
Here's why the Oscar Health stock price is in a bull run
Published: October 07, 2025 by: Invezz
Sentiment: Positive
Oscar Health stock price has been in a strong uptrend in the past few weeks as the company shared plans on integrating artificial intelligence (AI) into its business. OSCR surged to a high of $24.2, its highest level since June 2021.
Read More
Oscar Health, Inc. (OSCR) Outperforms Broader Market: What You Need to Know
Published: October 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Oscar Health, Inc. (OSCR) reached $19.28 at the closing of the latest trading day, reflecting a +2.01% change compared to its last close.
Read More
Oscar Health: Buy Now On ACA Concerns
Published: September 25, 2025 by: Seeking Alpha
Sentiment: Neutral
Oscar Health (OSCR) remains up 31% YTD as investors watch for developments on ACA enhanced subsidies, a key driver for its marketplace business. Policy risk looms with potential ACA subsidy expiration in 2026, but congressional pressure to extend could trigger a rally in OSCR shares. OSCR is leveraging ICHRA growth, AI-driven cost reductions, and improved customer experience to drive long-term margin expansion and membership gains.
Read More
Defiance Launches OSCX: The First 2X Long ETF for Oscar Health, Inc.
Published: September 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Long OSCR ETF (Ticker: OSCX).
Read More
Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds
Published: September 19, 2025 by: Benzinga
Sentiment: Positive
Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA (Affordable Care Act) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer is drawing Hims & Hers Health Inc HIMS style moonshot comparisons — and short sellers may be sitting on a powder keg.
Read More
Oscar Health: The Market Is Mispricing This Disruptor
Published: September 17, 2025 by: Seeking Alpha
Sentiment: Positive
Oscar Health stock is up 21% since my strong buy rating, outperforming the S&P 500's 4% return. Membership surpassed 2.0 million in June 2025, growing 28% year-over-year compared to just 13% ACA market growth. Expansion remains the primary catalyst, with coverage in 18 states and 446 counties, targeting 150 new metros by 2027.
Read More
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire
Published: August 25, 2025 by: Benzinga
Sentiment: Positive
Wall Street's most crowded shorts are starting to look like powder kegs. Rocket Companies Inc RKT, Oscar Health Inc OSCR, and Hims & Hers Health Inc HIMS are sitting at the top of the market's short-interest leaderboard, each with more than a quarter of their float sold short.
Read More
Oscar Health: Undervalued, But Not Without Risk
Published: August 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Oscar Health is deeply undervalued but faces high short-term uncertainty due to ACA-specific risks and sector-wide negative catalysts. The expiration of ACA subsidies, adverse selection, and new legislation threaten enrollment and profitability, making Oscar more vulnerable than diversified peers. Despite near-term headwinds, Oscar is uniquely positioned for long-term growth, especially if ICHRA adoption improves the ACA risk pool.
Read More
Wall Street Got Oscar All Wrong
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Negative
Oscar's Q2 revenue rose 29% YoY to $2.86 billion, with membership growing 28% to over 2 million. The reported 91.1% MLR was distorted by a $692 million retroactive risk adjustment; normalized MLR was ~85.1%. SG&A dropped to 18.7% of revenue, driven by automation, AI, and vendor optimization, unlocking $60 million in annualized savings.
Read More
Oscar Health: Underrated Growth Story With Big-Cap Ambitions
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Positive
Oscar Health is facing short-term ACA market concerns and negative analyst sentiment. I think it will be short-lived. The company is expanding into the high-potential ICHRA market, leveraging operational scale and AI-driven care coordination to improve margins. Current market concerns are cyclical, not structural. Valuation suggests growth rate is overlooked and company is mispriced.
Read More
Oscar Health: Barclays, UBS, And Wells Fargo Downgraded, But The Real Story Says Buy
Published: July 20, 2025 by: Seeking Alpha
Sentiment: Positive
I rate Oscar Health as a buy, viewing short-term regulatory headwinds as a buying opportunity given its long-term growth prospects. Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook, despite recent bearish analyst coverage. The company's strategic expansion into the ICHRA market and deployment of AI technology are key drivers for future revenue and cost efficiency.
Read More
Is $20 a Fair Valuation for Oscar Health (OSCR) — or a Stretch Too Far?
Published: July 20, 2025 by: 24/7 Wall Street
Sentiment: Neutral
Key Points in This Article: Oscar Health's (OSCR) stock surged in June 2025 due to strong Q1 earnings but crashed after Centene's guidance withdrawal and analyst downgrades.
Read More
Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Oscar Health, Inc. (OSCR) closed at $15.35 in the latest trading session, marking a +2.88% move from the prior day.
Read More
Why I'm Buying Oscar's Panic Dip
Published: July 03, 2025 by: Seeking Alpha
Sentiment: Negative
Centene's $1.8B ACA risk shock triggered a ~15-20% drop in Oscar's stock but didn't alter Q1 fundamentals. Oscar posted 42% revenue growth, expanding to 2 million members with a record-low 15.8% SG&A expense ratio. Barclays' downgrade highlights policy risk, projecting over 100bps MLR pressure and aggressive EPS cuts if subsidies expire.
Read More
Oscar Health: Should You Buy OSCR Stock At $17?
Published: July 03, 2025 by: Forbes
Sentiment: Neutral
On July 2nd, the health insurance sector underwent a notable decline following Centene (NYSE:CNC)'s retraction of its financial outlook, citing rising costs. Refer to – Centene: Is The Recent Decline In CNC Stock Justified?
Read More
Oscar Health: Should You Buy OSCR Stock At $17?
Published: July 03, 2025 by: Forbes
Sentiment: Neutral
On July 2nd, the health insurance sector underwent a notable decline following Centene (NYSE:CNC)'s retraction of its financial outlook, citing rising costs. Refer to – Centene: Is The Recent Decline In CNC Stock Justified?
Read More
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
Oscar Health, Inc. (OSCR) concluded the recent trading session at $16.62, signifying a -18.73% move from its prior day's close.
Read More
Oscar Health (OSCR) Soars 7.8%: Is Further Upside Left in the Stock?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Oscar Health (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
About Oscar Health, Inc. (OSCR)
- IPO Date 2021-03-03
- Website https://www.hioscar.com
- Industry Medical - Healthcare Plans
- CEO Mark Thomas Bertolini
- Employees 2400